Joe Mellor, PhD CSO, Co-founderseqWell The landscape of next-generation sequencing (NGS) continues to be defined by astonishing technological progress. We…

Beate Mueller-TiemannChief Technology OfficerCytiva 2026 will be a pivotal year for biopharma. From digital transformation to an AI revolution to…

Moira Lynch Director, Innovation, Strategic Projects, Bioproduction Thermo Fisher Scientific The bioproduction industry stands at a pivotal intersection, its trajectory…

The green shoots suggesting a comeback was in sight for biotech stocks last year have mostly grown into proverbial flowering…

In the past decade, genomic technologies have evolved from specialized research tools to crucial engines of discovery and clinical translation.…

A major breakthrough in cancer drug delivery took place in 1995, when the FDA approved the first nanodrug, Doxil—a liposomal…

Last September, Immusoft became the first company to deliver ex vivo cell & gene therapy (CGT) therapeutics to redose a…

Li Qu, PhDDirector, DMPK ServicesWuXi AppTec Antibody-drug conjugates (ADCs) continue to reshape the oncology landscape by combining the target specificity…